消糜汤治疗肝胃不和证糜烂性胃炎临床研究  

Clinical Studies of Xiaomi Decoction Treatment of Incoordination Between Liver and Stomach Type of Erosive Gastritis

作　　者：龚新益[1] 

机构地区：[1]枣阳市第一人民医院,湖北枣阳441200

出　　处：《中医学报》2014年第3期411-413,共3页Acta Chinese Medicine

摘　　要：目的:探讨消糜汤治疗肝胃不和证糜烂性胃炎的临床疗效。方法:将60例肝胃不和证糜烂性胃炎患者随机分为观察组和对照组。对照组30例给予雷尼替丁治疗,观察组30例采用消糜汤治疗。观察并对比两组患者的中医证候量化积分及临床疗效。结果:观察组患者的治愈率,显效率和总有效率与对照组基本相当,两组比较不具有显著统计差异(P>0.05);在中医证候量化积分上,两组患者治疗后均明显好于治疗前,具有显著统计学差异(P<0.05),但治疗后观察组患者的中医证候量化积分与对照组比较,不具有显著统计学差异(P>0.05);经胃镜检查,两组患者治疗前后疗效比较,具有显著统计学差异(P<0.05),但两组治疗后比较,差异无统计学意义(P>0.05),同时随访得出,观察组患者复发率明显低于对照组,差异有显著统计学意义(P<0.05),但两组均发现明显不良反应。结论:对于肝胃不和证糜烂性胃炎的治疗,临床上使用雷尼替丁和消糜汤的疗效无明显差异,但是消糜汤作为中医辨证方剂,未发现明显不良反应,能有效降低复发率,明显改善患者的生活质量。Objective：To investigate the clinical efficacy of Xiaomishuan soup in treating liver and stomach un adjustment type of erosive gastritis. Methods ：60 cases of disharmony of liver and erosive gastritis patients were randomly divided into observation group and control group. Control group of 30 patients given ranitidine treatment, observation group, 30 cases were Xiaomi decoction. TCM symptoms ob- served and compared the two groups were quantified integration and clinical efficacy. Results ： The cure rate of patients, significant effi- ciency and total efficiency is roughly equal to the control group, the two groups was not significant statistical difference （ P 〉 0.05 ） ; quantify symptoms in the integration of traditional Chinese medicine, the two groups of patients were significantly better prior to treat- ment, with statistically significant differences （P 〈 0.05 ）, but the TCM symptoms after treatment, patients in the observation group and control group quantization points, does not have a statistically significant difference （P 〉 0.05 ） ;by endoscopy, two groups of patients be- fore and after treatment efficacy, with statistically significant differences （ P 〈 0.05 ）, but after treatment, the difference was not statisti- cally significant （ P 〉 0.05 ） , while the follow-up results, the relapse rate of patients in the observation group was significantly lower than the control group, the difference was statistically significant （P 〈 0. 05 ）, but the two groups were found significant adverse reactions. Conclusion：For the incoordination between liver and erosive gastritis treatment,without the use of ranitidine and Xiaomi soup clinically significant difference in efficacy, but Xiaomi soup as TCM prescriptions found no significant adverse reactions, can effectively reduce the recurrence rates, significantly improving the quality of life of patients.

关 键 词：糜烂性胃炎 肝胃不和证 消糜汤 雷尼替丁 

分 类 号：R259.733[医药卫生—中西医结合]